Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
-
Fourth Quarter Results Total revenues of $50.6 million, a 13% year-over-year improvement and exceeding the high end of prior guidanceOperating income of $5.2 million increased 78% year-over-year,...
-
CHAPEL HILL, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Kelly Hadiaris has re-joined the Company...
-
MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that...
-
Fourth Quarter Revenue Increased 20% to a Record $23.4 Million Full Year 2025 Revenue Increased 20% to $90.3 Million, Generating GAAP EPS of $0.91 BOCA RATON, Fla., March 04, 2026 (GLOBE...
-
BERKELEY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its...
-
Lifecore Biomedical and Indomo sign new agreement to support innovative drug/device combination acne treatment.
-
MIRAMAR, Fla., March 04, 2026 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”), a racing game developer, publisher and esports ecosystem provider of...
-
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026; Type A meeting with FDA expected to occur within 30 daysOn track to submit regulatory applications for...
-
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on March...